• 2963 Citations
20012024

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Certifications and Licenses

Hematology
Medical Oncology

Training Experience

2001Residency, Dalhousie University, Canada
2004Fellowship, Univ. of Illinois Hospital

Education/Academic qualification

MD, McGill University

… → 1998

Research interests

  • Head and Neck Cancer
  • Salivary Gland Tumors
  • Sarcomas
  • Thyroid Cancer

Fingerprint Dive into the research topics where Mark Agulnik is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants

Research Output

  • 2963 Citations
  • 53 Article
  • 25 Review article
  • 3 Comment/debate
  • 1 Short survey

Pharmacokinetics of doxorubicin following concomitant intravenous administration of olaratumab (IMC-3G3) to patients with advanced soft tissue sarcoma

Villalobos, V. M., Mo, G., Agulnik, M., Pollack, S. M., Rushing, D. A., Singh, A., Van Tine, B. A., McNaughton, R., Decker, R. L., Zhang, W., Shahir, A. & Cronier, D. M., Feb 1 2020, In : Cancer medicine. 9, 3, p. 882-893 12 p.

Research output: Contribution to journalArticle

Open Access
  • A phase II clinical study of 13-deoxy, 5-iminodoxorubicin (GPX-150) with metastatic and unresectable soft tissue sarcoma

    Van Tine, B. A., Agulnik, M., Olson, R. D., Walsh, G. M., Klausner, A., Frank, N. E., Talley, T. T. & Milhem, M. M., Jun 1 2019, In : Cancer medicine. 8, 6, p. 2994-3003 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • Ectopic hamartomatous thymoma in an immunocompromised male

    Waters, D., Obeidin, F., Alexiev, B. A., Rao, M. S., Peabody, T. D., Agulnik, M. & Yeldandi, A., Sep 2019, In : Pathology Research and Practice. 215, 9, 152497.

    Research output: Contribution to journalArticle

  • Piloting a financial counseling intervention for patients with cancer receiving chemotherapy

    Kircher, S. M., Yarber, J., Rutsohn, J., Guevara, Y., Lyleroehr, M., Jackson, H. A., Walradt, J., Desai, B., Mulcahy, M., Kalyan, A., Benson, A. B., Agulnik, M., Mohindra, N., DeSouza, J. & Garcia, S. F., Mar 1 2019, In : Journal of oncology practice. 15, 3, p. E202-E210

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Randomized double-blind phase II study of regorafenib in patients with metastatic osteosarcoma

    Davis, L. E., Bolejack, V., Ryan, C. W., Ganjoo, K. N., Loggers, E. T., Chawla, S., Agulnik, M., Livingston, M. B., Reed, D., Keedy, V., Rushing, D., Okuno, S., Reinke, D. K., Riedel, R. F., Attia, S., Mascarenhas, L. & Maki, R. G., Jan 1 2019, In : Journal of Clinical Oncology. 37, 16, p. 1424-1431 8 p.

    Research output: Contribution to journalArticle

  • 10 Scopus citations